HIV Incidence in Botswana Rural Communities With High Antiretroviral Treatment Coverage: Results From the Botswana Combination Prevention Project, 2013-2017.
Journal
Journal of acquired immune deficiency syndromes (1999)
ISSN: 1944-7884
Titre abrégé: J Acquir Immune Defic Syndr
Pays: United States
ID NLM: 100892005
Informations de publication
Date de publication:
01 09 2022
01 09 2022
Historique:
received:
17
11
2021
accepted:
19
04
2022
pubmed:
11
5
2022
medline:
19
8
2022
entrez:
10
5
2022
Statut:
ppublish
Résumé
The Botswana Combination Prevention Project demonstrated a 30% reduction in community HIV incidence through expanded HIV testing, enhanced linkage to care, and universal antiretroviral treatment and exceeded the Joint United Nations Programme on HIV/AIDS 90-90-90 targets. We report rates and characteristics of incident HIV infections. The Botswana Combination Prevention Project was a community-randomized controlled trial conducted in 30 rural/periurban Botswana communities from 2013 to 2017. Home-based and mobile HIV-testing campaigns were conducted in 15 intervention communities, with 39% of participants testing at least twice. We assessed the HIV incidence rate [IR; number of new HIV infections per 100 person-years (py) at risk] among repeat testers and risk factors with a Cox proportional hazards regression model. During 27,517 py, 195 (women: 79%) of 18,597 became HIV-infected (0.71/100 py). Women had a higher IR (1.01/100 py; 95% confidence interval: 0.99 to 1.02) than men (0.34/100 py; 95% confidence interval: 0.33 to 0.35). The highest IRs were among women aged 16-24 years (1.87/100 py) and men aged 25-34 years (0.56/100 py). The lowest IRs were among those aged 35-64 years (women: 0.41/100 py; men: 0.20/100 py). The hazard of incident infection was the highest among women aged 16-24 years (hazard ratio = 7.05). Sex and age were significantly associated with incidence (both P < 0.0001). Despite an overall reduction in HIV incidence and approaching the United Nations Programme on HIV/AIDS 95-95-95 targets, high HIV incidence was observed in adolescent girls and young women. These findings highlight the need for additional prevention services (pre-exposure prophylaxis and DREAMS) to achieve epidemic control in this subpopulation and increased efforts with men with undiagnosed HIV.
Sections du résumé
BACKGROUND AND SETTING
The Botswana Combination Prevention Project demonstrated a 30% reduction in community HIV incidence through expanded HIV testing, enhanced linkage to care, and universal antiretroviral treatment and exceeded the Joint United Nations Programme on HIV/AIDS 90-90-90 targets. We report rates and characteristics of incident HIV infections.
METHODS
The Botswana Combination Prevention Project was a community-randomized controlled trial conducted in 30 rural/periurban Botswana communities from 2013 to 2017. Home-based and mobile HIV-testing campaigns were conducted in 15 intervention communities, with 39% of participants testing at least twice. We assessed the HIV incidence rate [IR; number of new HIV infections per 100 person-years (py) at risk] among repeat testers and risk factors with a Cox proportional hazards regression model.
RESULTS
During 27,517 py, 195 (women: 79%) of 18,597 became HIV-infected (0.71/100 py). Women had a higher IR (1.01/100 py; 95% confidence interval: 0.99 to 1.02) than men (0.34/100 py; 95% confidence interval: 0.33 to 0.35). The highest IRs were among women aged 16-24 years (1.87/100 py) and men aged 25-34 years (0.56/100 py). The lowest IRs were among those aged 35-64 years (women: 0.41/100 py; men: 0.20/100 py). The hazard of incident infection was the highest among women aged 16-24 years (hazard ratio = 7.05). Sex and age were significantly associated with incidence (both P < 0.0001).
CONCLUSIONS
Despite an overall reduction in HIV incidence and approaching the United Nations Programme on HIV/AIDS 95-95-95 targets, high HIV incidence was observed in adolescent girls and young women. These findings highlight the need for additional prevention services (pre-exposure prophylaxis and DREAMS) to achieve epidemic control in this subpopulation and increased efforts with men with undiagnosed HIV.
Identifiants
pubmed: 35537094
doi: 10.1097/QAI.0000000000003017
pii: 00126334-202209010-00002
pmc: PMC9388617
mid: NIHMS1804291
doi:
Substances chimiques
Anti-Retroviral Agents
0
Types de publication
Journal Article
Randomized Controlled Trial
Research Support, U.S. Gov't, Non-P.H.S.
Research Support, U.S. Gov't, P.H.S.
Langues
eng
Sous-ensembles de citation
IM
Pagination
9-16Subventions
Organisme : CGH CDC HHS
ID : U2G GH000419
Pays : United States
Organisme : CGH CDC HHS
ID : U01 GH000447
Pays : United States
Organisme : CGH CDC HHS
ID : U2G GH000073
Pays : United States
Organisme : PEPFAR
Pays : United States
Organisme : CGH CDC HHS
ID : U2G GH001911
Pays : United States
Informations de copyright
Copyright © 2022 Wolters Kluwer Health, Inc. All rights reserved.
Déclaration de conflit d'intérêts
The authors have no conflicts of interest to disclose.
Références
UNAIDS. Joint United Nations Programme on HIV/AIDS. 90–90-90–An ambitious treatment target to help end the AIDS epidemic. 2021. Available at: https://www.unaids.org/sites/default/files/media_asset/90-90-90_en.pdf . Accessed March 17, 2021.
Havlir DV, Balzer LB, Charlebois ED, et al. HIV testing and treatment with the use of a community health approach in rural Africa. N Engl J Med. 2019;381:219–229.
Hayes RJ, Donnell D, Floyd S, et al. Effect of universal testing and treatment on HIV incidence–HPTN 071 (PopART). N Engl J Med. 2019;381:207–218.
Iwuji CC, Orne-Gliemann J, Larmarange J, et al. Universal test and treat and the HIV epidemic in rural South Africa: a phase 4, open-label, community cluster randomised trial. Lancet HIV. 2018;5:e116–e125.
Makhema J, Wirth KE, Pretorius Holme M, et al. Universal testing, expanded treatment, and incidence of HIV infection in Botswana. N Engl J Med. 2019;381:230–242.
Wirth KE, Gaolathe T, Pretorius Holme M, et al. Population uptake of HIV testing, treatment, viral suppression, and male circumcision following a community-based intervention in Botswana (Ya Tsie/BCPP): a cluster-randomised trial. Lancet HIV. 2020;7:e422–e433.
Making UNAIDS. The End of AIDS Real: Consensus Building Around What We Mean by “Epidemic Control”; 2018. Available at: https://www.unaids.org/sites/default/files/media_asset/glion_oct2017_meeting_report_en.pdf . Accessed March 31, 2022.
Galvani AP, Pandey A, Fitzpatrick MC, et al. Defining control of HIV epidemics. Lancet HIV. 2018;5:e667–e670.
Gaolathe T, Wirth KE, Holme MP, et al. Botswana's progress toward achieving the 2020 UNAIDS 90-90-90 antiretroviral therapy and virological suppression goals: a population-based survey. Lancet HIV. 2016;3:e221–e230.
Brown K, Williams DB, Kinchen S, et al. Status of HIV epidemic control among adolescent girls and young women aged 15–24 years—seven African countries, 2015–2017. MMWR Morb Mortal Wkly Rep. 2018;67:29–32.
Lebelonyane R, Bachanas P, Block L, et al. To achieve 95-95-95 targets we must reach men and youth: high level of knowledge of HIV status, ART coverage, and viral suppression in the Botswana Combination Prevention Project through universal test and treat approach. PLoS One. 2021;16:e0255227.
Probert MH W, Xi X, Sauter R, et al. Quantifying the Contribution of Different Aged Men and Women to Onwards Transmission of HIV-1 in Generalised Epidemics in Sub-Saharan Africa: A Modelling and Phylogenetics Approach From the HPTN 071 (PopART) Trial. 2021. Available at: https://ora.ox.ac.uk/objects/uuid:ca8ec492-075a-4fdf-a98a-85511ea51b9a . Accessed March 23, 2021.
Mmalane MO, Sento B, Leidner J, et al. Association of mobility with HIV recent infections and viremia in Botswana. Abstract #936. Conference on Retroviruses and Opportunistic Infections, Boston, MA, March 4–7, 2018.
Novitsky V, Zahralban-Steele M, Moyo S, et al. Mapping of HIV-1C transmission networks reveals extensive spread of viral lineages across villages in Botswana treatment-as-prevention trial. J Infect Dis. 2020;222:1670–1680.
Lalla-Edward ST, Fobosi SC, Hankins C, et al. Healthcare programmes for truck drivers in sub-Saharan Africa: a systematic review and meta-analysis. PLoS One. 2016;11:e0156975.
Ministry of Health, Botswana. Handbook of the Botswana 2016 Integrated HIV Clinical Care Guidelines; 2016. Available at: https://www.moh.gov.bw/Publications/Handbook_HIV_treatment_guidelines.pdf . Accessed March 29, 2022.
Marukutira T, Block L, Alwano MG, et al. Comparison of knowledge of HIV status and treatment coverage between non-citizens and citizens: Botswana Combination Prevention Project (BCPP). PLoS One. 2019;14:e0221629.
Tanser F, Bärnighausen T, Vandormael A, et al. HIV treatment cascade in migrants and mobile populations. Curr Opin HIV AIDS. 2015;10:430–438.
UNAIDS. The Gap Report 2014. 2014. Available at: http://www.unaids.org/sites/default/files/media_asset/UNAIDS_Gap_report_en.pdf . Accessed March 23, 2021.
WHO. Consolidated Guidelines on HIV Prevention, Diagnosis, Treatment and Care for Key Populations–2016 Update. 2016. Available at: http://apps.who.int/iris/bitstream/handle/10665/246200/9789241511124-eng.pdf . Accessed March 29, 2022.
UNAIDS. Prevailing Against Pandemics by Putting People at the Centre, World AIDS Day Report. 2020. Available at: https://aidstargets2025.unaids.org/assets/images/prevailing-against-pandemics_en.pdf . Accessed April 1, 2022.
Kim AA, Behel S, Northbrook S, et al. Tracking with recency assays to control the epidemic: real-time HIV surveillance and public health response. AIDS. 2019;33:1527–1529.